Evidence for undetected malaria infection in non-immune Australian travellers not taking chemoprophylaxis

Acta Tropica

Volumn 99, Issue 1, 2006, Pages 62-66

  Seed, Clive R ^a   Hamzah, Juliana ^b   Davis, Timothy M E ^b  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Antimalarial chemoprophylaxis; Malaria; Seropositivity; Travellers

Indexed keywords

ANTIGEN; ANTIMALARIAL AGENT; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; DOXYCYCLINE; FANSIDAR; MEFLOQUINE; PROTOZOON ANTIBODY;

ANTIBODY; DISEASE RESISTANCE; DRUG; HEALTH RISK; IMMUNOASSAY; MALARIA; WORLD HEALTH ORGANIZATION;

ADULT; ARTICLE; AUSTRALIA; BLOOD DONOR; CHEMOPROPHYLAXIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH RISK POPULATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALARIA; PROTOZOAL INFECTION; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; TRAVEL; WORLD HEALTH ORGANIZATION;

ANIMALS; ANTIBODIES, PROTOZOAN; BLOOD DONORS; CHEMOPREVENTION; ENDEMIC DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALARIA; PLASMODIUM; SEROEPIDEMIOLOGIC STUDIES; TRAVEL; WESTERN AUSTRALIA;

EID: 33748741553     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2006.07.003     Document Type: Article

References (19)

1. Centers for Disease Control. Local transmission of Plasmodium vivax malaria-Palm Beach County, Florida, 2003. Morb. Mortal. Wkly Rep. 52 (2003) 908-911
2. Charles D.M., Hart J., Davis W.A., Sullivan E., Dowse G.K., and Davis T.M.E. Notifications of imported malaria in Western Australia, 1990-2001: incidence, associated factors and chemoprophylaxis. Med. J. Aust. 182 (2005) 164-167
3. Chiodini P.L., Hartley S., Hewitt P.E., Barbara J.A., Lalloo K., Bligh J., and Voller A. Evaluation of a malaria antibody ELISA and its value in reducing potential wastage of red cell donations from blood donors exposed to malaria, with a note on a case of transfusion-transmitted malaria. Vox Sang. 73 (1997) 143-148
4. Collins W.E., and Jeffrey G.M. A retrospective examination of sporozoite- and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity during primary infection. Am. J. Trop. Med. Hyg. 61 Suppl. 1 (1999) 4-19
5. Contreras C.E., Pance A., Marcano N., Gonzalez N., and Bianco N. Detection of specific antibodies to Plasmodium falciparum in blood bank donors from malaria-endemic and non-endemic areas of Venezuela. Am. J. Trop. Med. Hyg. 60 (1999) 948-953
6. Davidson N., Woodfield G., and Henry S. Malarial antibodies in Auckland blood donors. N. Z. Med. J. 112 (1999) 181-183
7. Giha H.A., Staalsoe T., Dodoo D., Roper C., Satti G.M., Arnot D.E., Hviid L., and Theander T.G. Antibodies to variable Plasmodium falciparum-infected erythrocyte surface antigens are associated with protection from novel malaria infections. Immunol. Lett. 71 (2000) 117-126
8. Health Protection Agency, 2005. Illness in England, Wales, and Northern Ireland associated with foreign travel. Annual Report 2005. Available at: http://www.hpa.org.uk/hpa/publications/travel_2005/arthropod.pdf (accessed December 2005).
9. Kitchen A.D., Lowe P.J., Lalloo K., and Chiodini P.L. Evaluation of a malarial antibody assay for use in the screening for blood and tissue products for clinical use. Vox Sang. 87 (2004) 150-155
10. Nguyen M.H., Davis T.M., Cox-Singh J., Hewitt S., Tran Q.T., Tran B.K., Nguyen T.H., Vo N.P., Doan H.N., and Le D.C. Treatment of uncomplicated falciparum malaria in southern Vietnam: can chloroquine or sulfadoxine-pyrimethamine be reintroduced in combination with artesunate?. Clin. Infect. Dis. 37 (2003) 1461-1466
11. Nothdurft H.D., Jelinek T., Bluml A., von Sonnenburg F., and Loscher T. Seroconversion to circumsporozoite antigen of Plasmodium falciparum demonstrates a high risk of malaria transmission in travelers to East Africa. Clin. Infect. Dis. 28 (1999) 641-642
12. Prociv P. Deaths of Australians overseas. Med. J. Aust. 163 (1995) 27-30
13. Sanchez J.L., Bendet I., Grogl M., Lima J.B., Pang L.W., Guimaraes M.F., Guedes C.M., Milhous W.K., Green M.D., and Todd G.D. Malaria in Brazilian military personnel deployed to Angola. J. Travel Med. 7 (2000) 275-282
14. Seed C.R., Cheng A., Davis T.M.E., Bolton W.V., Keller A.J., Kitchen A., and Cobain T.J. The efficacy of a malaria antibody enzyme immunoassay for establishing the reinstatement status of blood donors potentially exposed to malaria. Vox Sang. 88 (2005) 98-106
15. Shah S., Filler S., Causer L.M., Rowe A.K., Bloland P.B., Barber A.M., Roberts J.M., Desai M.R., Parise M.E., and Steketee R.W. Malaria surveillance-United States, 2002. M.M.W.R. Surveill. Summ. 53 SS01 (2004) 21-34. http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5301a2.htm Available at: www.cdc.gov/mmwr/preview/mmwrhtml/ss5301a2.htm. (accessed 1st December 2005).
16. Wilder-Smith A., Khairullah N.S., Song J.H., Chen C.Y., and Torresi J. Travel health knowledge, attitudes and practices among Australasian travellers. J. Travel Med. 11 (2004) 9-15
17. World Health Organisation, 2005a. International Travel and Health. Country list. http://www.who.int/ith/countries/en/ (accessed 1st December 2005).
18. World Health Organisation, 2005b. International Travel and Health. Vaccination requirements and malaria situation. http://www.who.int/ith/countries/vaccination/en/index.html (accessed 8th August 2005).
19. Zucker J.E. Changing patterns of autochthonous malaria transmission in the United States: a review of recent outbreaks. Emerg. Infect. Dis. 2 (1996) 37-43